Clinical Trial: Geographic Atrophy Treatment Evaluation
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: The Safety and Efficacy of AL-8309B Ophthalmic Solution for the Treatment of Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Brief Summary: The purpose of this study was to evaluate the safety and efficacy of AL-8309B Ophthalmic Solution versus Vehicle administered as a topical ocular drop for the treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
Detailed Summary:
Sponsor: Alcon Research
Current Primary Outcome: Mean Annualized Lesion Enlargement Rate From Baseline as Assessed With Fundus Autofluorescence Imaging [ Time Frame: Baseline, up to Month 30 ]
Original Primary Outcome: Mean annualized atrophic lesion growth [ Time Frame: 24 months ]
Current Secondary Outcome:
Original Secondary Outcome: Visual acuity [ Time Frame: 24 months ]
Information By: Alcon Research
Dates:
Date Received: April 27, 2009
Date Started: April 2009
Date Completion:
Last Updated: June 4, 2014
Last Verified: June 2014